Evidence map›Paper›PMID 40844882›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2025

Brief Report: Predictors of Concurrent Sexual Partnerships and Association With Recent HIV Infection in a Large Population-Based Survey in Botswana.

Sikhulile Moyo, Etienne K Yankinda, Kathleen E Hurwitz, Kara Bennett, Unoda A Chakalisa, Tendani Gaolathe, Lillian Okui, Jean Leidner, Coulson Kgathi, Tumalano Sekoto and 11 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sikhulile MoyoBotswana Harvard Health Partnership, Gaborone, Botswana.ORCID 0000-0003-3821-4592
Etienne K YankindaBotswana Harvard Health Partnership, Gaborone, Botswana.
Kathleen E HurwitzDepartment of Strategic Information, Botswana-University of Maryland School of Medicine Health Initiative, Gaborone, Botswana.
Kara BennettDepartment of Strategic Information, Botswana-University of Maryland School of Medicine Health Initiative, Gaborone, Botswana.ORCID 0000-0002-9465-8983
Unoda A ChakalisaBotswana Harvard Health Partnership, Gaborone, Botswana.ORCID 0000-0002-5146-0491
Tendani GaolatheBotswana Harvard Health Partnership, Gaborone, Botswana.
Lillian OkuiBotswana Harvard Health Partnership, Gaborone, Botswana.ORCID 0009-0001-1716-0890
Jean LeidnerTarget RWE, Durham, NC.
Coulson KgathiBotswana Harvard Health Partnership, Gaborone, Botswana.
Tumalano SekotoBotswana Harvard Health Partnership, Gaborone, Botswana.ORCID 0009-0005-1903-8329
Erik van WidenfeltBotswana Harvard Health Partnership, Gaborone, Botswana.
M Lendsey MeltonDepartment of Immunology and Infectious Diseases, Harvard T.H Chan School of Public Health, Boston, MA.
Refeletswe LebelonyaneGoodtables Data Consulting, Norman, OK.
Simani GaseitsiweBotswana Harvard Health Partnership, Gaborone, Botswana.
Mompati O MmalaneBotswana Harvard Health Partnership, Gaborone, Botswana.
Vlad NovitskyDepartment of Immunology and Infectious Diseases, Harvard T.H Chan School of Public Health, Boston, MA.
Joseph M MakhemaBotswana Harvard Health Partnership, Gaborone, Botswana.
Scott L Dryden-PetersonDivision of Infectious Diseases, Department of Medicine, Brown University Alpert Medical School, Providence, RI; and.
Molly P HolmeDepartment of Immunology and Infectious Diseases, Harvard T.H Chan School of Public Health, Boston, MA.
Max EssexDepartment of Immunology and Infectious Diseases, Harvard T.H Chan School of Public Health, Boston, MA.
Shahin LockmanBotswana Harvard Health Partnership, Gaborone, Botswana.ORCID 0000-0002-5384-9716

Funding

Training in HIV Genomics, Treatment, and Cure Research in BotswanaD43TW009610 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI SHAHIN LOCKMAN, Joseph Moeketsi Makhema · 2013 to 2026
$4.4M
Mentoring in Patient-Oriented HIV Research in the Era of Universal ARTK24AI131928 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAHIN LOCKMAN · 2017 to 2026
$1.9M
Viral Diversity an Innovative Biomarker for Refining Estimates of HIV IncidenceK43TW012350 · FIC · THE BOTSWANA HARVARD HEALTH PARTNERSHIP · PI Sikhulile Moyo · 2022 to 2026
$682k
CGH CDC HHS U01 GH000447CGH CDC HHS U2G GH001911European and Developing Countries Clinical Trials Partnership CSA2020NoE-3104FIC NIH HHS D43 TW009610FIC NIH HHS K43 TW 012350FIC NIH HHS K43 TW012350Gates Foundation INV-033558NIAID NIH HHS K24 AI131928
6 · The paper itself

Abstract

backgroundMultiple concurrent sexual partnerships (MCP) may drive new HIV infections. We investigated the association between MCP and recent or incident HIV infection in a cluster-randomized HIV prevention trial that followed a population-based HIV incidence cohort across 30 communities in Botswana.

methodsWe used structured questionnaires to evaluate MCP for prior 12 months, defined as either (1) MCP per UNAIDS definition or (2) concurrent sexual relationship per survey questions. Recent HIV infection was determined using an avidity assay-based algorithm or seroconversion within 2 years, and incident infection was determined through annual HIV testing for up to 3 years. We estimated prevalence ratios (PRs) and 95% confidence intervals (CIs) for MCP predictors using univariate and multivariable Poisson regression with log-link and fixed effects for matched pairs.

resultsWe included 11,965 (94.9%) of the 12,610 participants in the Botswana Combination Prevention Project with sexual history data. Among 9363 sexually active persons in prior 12 months, 2770 (29.6%) were engaged in MCP. Factors independently associated with MCP included male sex (aPR = 1.57; 95% CI: 1.45 to 1.71), age < 25 years (aPR = 1.25, 95% CI: 1.01 to 1.56), alcohol consumption ≥ 2 times/week (aPR = 1.38, 95% CI: 1.26 to 1.51), transactional sex (aPR = 1.69, 95% CI: 1.49 to 1.92), having a partner with MCP (aPR = 1.82, 95% CI: 1.65 to 2.02), and intergenerational sex (partners 10 years younger: aPR = 1.16, 95% CI: 1.06 to 1.28 or 10 years older: aPR = 1.32, 95% CI: 1.15 to 1.51). Reporting prior MCP was associated with HIV seroconversion during follow-up (aPR= 1.28, 95% CI: 1.05 to 1.57) but not with prevalent or recent HIV infection at baseline.

conclusionsMCP was common and associated with incident HIV infection. People reporting MCP may benefit from pre-exposure prophylaxis.

Indexed as

HIV InfectionsSexual BehaviorSexual PartnersAdolescentAdultBotswanaFemaleHumansIncidenceMaleMiddle AgedPrevalenceRisk FactorsSurveys and QuestionnairesYoung Adultconcurrent sexual partnershipsHIV seroconversionrecent HIV infection

Identifiers

PMID40844882
PMCPMC12494065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.